Investing In a Better Future

If you’ve come to this page, we hope you are as excited about Bicycle as we are. Our goal is to be one of the world’s leading solid tumor therapeutics companies. Please give us a call or send us an email if you have questions about our science, clinical programs, strategy or any other aspect of the Bicycle story.
Press
Date
Title
Date
02/28/23
Title
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Date
02/28/23
Title
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Date
02/14/23
Title
Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009
Date
02/08/23
Title
Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference